BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
See today's BioWorld
Home
» Other news to note for Jan. 9, 2023
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for Jan. 9, 2023
Jan. 9, 2023
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ammax, Aqemia, Askbio, Astellas, Astrazeneca, Basilea, Bayer, Calithera, Caris, Celltrion, Centogene, Concertai, Cymabay, Denali, Editas, Ena, Entrada, Epivax, Evopoint, Fosun, Ginkgo, Greenlight, Henlius, Kaken, Klinge, Prokarium, Rani, Recode, Roche, Servier, Sonnet, Twist.
BioWorld
Briefs
Other news to note
Coronavirus